Clinical Trial to Evaluation the Safety and Efficacy of GR-MD-02 for the Treatment of Liver Fibrosis and Resultant Portal Hypertension in Patients With Nash Cirrhosis
Clinical trial NCT02462967 · COMPLETED
Trial details
- NCT number
- NCT02462967
- Sponsor
- Galectin Therapeutics Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-06-01
- Primary completion
- 2017-10-01
- Enrollment
- 162
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.